Repare Therapeutics Inc

General ticker "RPTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $113.4M

Repare Therapeutics Inc does not follow the US Stock Market performance with the rate: -25.2%.

Estimated limits based on current volatility of 3.9%: low 1.23$, high 1.48$

Factors to consider:

  • Current price 61.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.51$, 8.92$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.70$, 9.01$]

Financial Metrics affecting the RPTX estimates:

  • Negative: Non-GAAP EPS, $ of -2.23 <= 0.10
  • Negative: Operating profit margin, % of -69.45 <= 1.03
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Operating cash flow per share per price, % of -33.36 <= 2.35
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term RPTX quotes

Long-term RPTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $7.60MM $131.83MM $51.13MM
Operating Expenses $116.26MM $151.63MM $167.36MM
Operating Income $-108.66MM $-19.80MM $-116.22MM
Non-Operating Income $0.07MM $5.90MM $13.04MM
R&D Expense $90.05MM $119.07MM $133.59MM
Income(Loss) $-108.59MM $-13.90MM $-103.18MM
Taxes $-1.68MM $15.15MM $-9.38MM
Profit(Loss) $-106.91MM $-29.05MM $-93.80MM
Stockholders Equity $288.42MM $279.52MM $212.08MM
Inventory $0.00MM $2.81MM $0.00MM
Assets $368.71MM $364.07MM $253.90MM
Operating Cash Flow $-85.80MM $0.32MM $-127.16MM
Capital expenditure $1.69MM $0.60MM $1.94MM
Investing Cash Flow $-1.68MM $-175.78MM $78.04MM
Financing Cash Flow $95.56MM $0.88MM $0.84MM
Earnings Per Share* $-2.83 $-0.69 $-2.23

* EPS are Split Adjusted, recent splits may be reflected with a delay.